Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
No Korea-Originated New Drugs Approved Domestically In 2023
But Carvykti Becomes Second CAR-T
Apr 22 2024
•
By
Jung Won Shin
Korea’s Homegrown Novel Drug Approvals Continue To Drop • Source: Shutterstock
More from South Korea
More from Asia